Atlas Venture Life Science Advisors as of Dec. 31, 2023
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 16 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 17.8 | $149M | 5.9M | 25.46 | |
| Disc Medicine Common Stock (IRON) | 17.6 | $148M | 2.6M | 57.76 | |
| Dyne Therapeutics Common Stock (DYN) | 15.7 | $132M | 9.9M | 13.30 | |
| Third Harmonic Bio Common Stock (THRD) | 14.2 | $120M | 11M | 10.97 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 13.2 | $111M | 7.6M | 14.60 | |
| Korro Bio Common Stock (KRRO) | 6.4 | $54M | 1.1M | 47.93 | |
| Aerovate Therapeutics Common Stock (AVTE) | 5.5 | $46M | 2.0M | 22.63 | |
| Vigil Neuroscience Common Stock (VIGL) | 2.3 | $20M | 5.8M | 3.38 | |
| Replimune Group Common Stock (REPL) | 2.1 | $18M | 2.1M | 8.43 | |
| Generation Bio Common Stock | 1.6 | $14M | 8.3M | 1.65 | |
| Ikena Oncology Common Stock (IKNA) | 1.2 | $9.9M | 5.0M | 1.97 | |
| Akero Therapeutics Common Stock (AKRO) | 1.0 | $8.4M | 359k | 23.35 | |
| AvroBio Common Stock (AVRO) | 0.7 | $6.2M | 4.5M | 1.36 | |
| Dianthus Therapeutics Common Stock (DNTH) | 0.3 | $2.5M | 237k | 10.40 | |
| Xilio Therapeutics Common Stock | 0.2 | $1.5M | 2.8M | 0.55 | |
| Spero Therapeutics Common Stock (SPRO) | 0.2 | $1.5M | 1.0M | 1.47 |
